170Tip A Phase I Study to Characterize the Safety and Tolerability of MP0317, a Tumor Targeting FAP Dependent CD40 Agonist DARPin®, in Patients with Relapsed/refractory Solid Tumors
ANNALS OF ONCOLOGY(2021)
关键词
Fibroblast Activation Protein
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要